SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC - VANDA PHARMACEUTICALS INC ownership

VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 179 filers reported holding VANDA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 3.07 and the average weighting 0.1%.

Quarter-by-quarter ownership
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC ownership history of VANDA PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2021$577,000
-31.9%
36,780
-25.5%
0.02%
-6.2%
Q3 2021$847,000
-31.1%
49,400
-13.6%
0.02%
-27.3%
Q2 2021$1,230,000
+48.2%
57,195
+3.5%
0.02%
+57.1%
Q1 2021$830,000
+409.2%
55,267
+345.7%
0.01%
+366.7%
Q4 2020$163,000
-69.4%
12,400
-73.4%
0.00%
-88.0%
Q2 2020$533,00046,6000.02%
Other shareholders
VANDA PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Palo Alto Investors LP 2,491,200$27,154,0002.37%
Profit Investment Management, LLC 281,890$3,071,0002.26%
Sio Capital Management, LLC 488,965$5,330,0002.00%
Zebra Capital Management LLC 14,766$161,0000.47%
Prairiewood Capital, LLC 50,165$547,0000.43%
TANG CAPITAL MANAGEMENT LLC 256,696$2,798,0000.42%
HUSSMAN STRATEGIC ADVISORS, INC. 156,000$1,700,0000.29%
GLOBEFLEX CAPITAL L P 100,843$1,099,0000.27%
Epoch Investment Partners, Inc. 2,757,646$30,059,0000.18%
EMC Capital Management 16,185$176,0000.15%
View complete list of VANDA PHARMACEUTICALS INC shareholders